genetic and epigenetic alterations

May 6, 2022

SOCS3 Acts as an Onco-immunological Biomarker With Value in Assessing the Tumor Microenvironment, Pathological Staging, Histological Subtypes, Therapeutic Effect, and Prognoses of Several Types of Cancer

Abstract The suppressor of cytokine signaling (SOCS) family contains eight members, including SOCS1–7 and CIS, and SOCS3 has been shown…

September 2, 2021

MXD3 as an onco-immunological biomarker encompassing the tumor microenvironment, disease staging, prognoses, and therapeutic responses in multiple cancer types

Keywords: MXD3, Immuno-oncology, Immunotherapy, Chemotherapy, Gene expression profiling, Immune-cell infiltration, T-cell exclusion, Genetic and epigenetic alterations Authors: Szu-Yuan Wu, Kuan-Chou…